Autoimmune Technologies
is working on several exciting discoveries in the field
of rheumatic diseases.
Autoimmune is currently conducting FDA clinical trials
of its APA Assay ELISA test kit, which is designed to
detect antibodies associated with most cases of fibromyalgia.
The Company believes that the presence of these antibodies
will support the proposal that fibromyalgia is a discrete
autoimmune disease in the same manner in which the discovery
of rheumatoid factors in the 1940s demonstrated that
rheumatoid arthritis is a discrete autoimmune disease.
For further information about fibromyalgia, click here.
The Company is also working on diagnostic tests for
systemic lupus erythematosus, Sjögren's syndrome,
Graves' disease and juvenile rheumatoid arthritis. Researchers
at Tulane University School of Medicine have discovered
a human retrovirus called the Human Intracisternal A-type
Particle, or HIAP. Their research strongly suggests
that this virus is the cause of all four of these disorders.
The Company believes that a test to detect antibodies
against this virus will be very valuable to patients
and physicians alike. For further information about
these disorders, click the following links:
Systemic Lupus Erythematosus,
Sjögren's Syndrome, Graves'
Disease, or Juvenile
Rheumatoid Arthritis.
|
